Sleep and breathing disorders in adults

Sleep Disorders: Diagnosis and Therapeutics

Volumn , Issue , 2008, Pages 526-535

  Jones, Mandy ^a   Morrell, Mary J ^b  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054922308     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (98)

1. Morrell MJ, Harty HR, Adams L, Guz A. Changes in total pulmonary resistance and PCO2 between wakefulness and sleep in normal human subjects. J Appl Physiol 1995; 78: 1339-49.
2. Henke K, Dempsey J, Kowitz J, Skatrud J. Effects of sleepinduced increases in upper airway resistance on ventilation. J Appl Physiol 1990; 69: 617-24.
3. Skatrud J, and Dempsey J. Relative effectiveness of acetazol - amide versus medroxyprogesterone acetate in correction of chronic carbon dioxide retention. J Appl Physiol 1983; 55:813-22.
4. Young TD, Palta M, Dempsey J et al. The occurrence of sleepdisordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
5. Vazir A, Hastings PC, Dayer M et al. A high prevalence of sleep disordered breathing in men with mild symptomatic heart failure secondary to left ventricular systolic dysfunction. Eur J Heart Fail 2007; 9: 243-50.
6. Beebe D, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioural deficits. J Sleep Res 2002; 11: 1-16.
7. Ancoli-Israel S, Klauber M, Stepnowsky C et al. Sleep-disordered breathing in African-American elderly. Am J Respir Crit Care Med 1995; 152: 1946-9.
8. Phillips B, Berry D, Schmitt F et al. Sleep-disordered breathing in the healthy elderly. Clinically significant? Chest 1992; 101:345-9.
9. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157: 144-8.
10. Young T, Shahar E, Nieto F et al; Sleep Heart Health Study Group. Predictors of sleep-disordered breathing in communitydwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162: 893-900.
11. Hader C, Schroeder A, Hinz M, Micklefield G, Rasche K. Sleep disordered breathing in the elderly: comparison of women and men. J Physiol Pharmacol 2005; 56: 85-91.
12. Ancoli-Israel S, Parker L, Sinaee R, Fell R, Kripke D. Sleep fragmentation in patients from a nursing home. J Gerontol 1989; 44: 18-21.
13. Redline S, Kump K, Tishler P, Browner I, Ferrette V. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med 1994; 149: 722-6.
14. Jordan A, McEvoy R. Gender differences in sleep apnea: epidemiology, clinical presentation and pathogenic mechanisms. Sleep Med Rev 2003; 7: 377-89.
15. Horner R, Innes JA, Morrell MJ, Shea SA, Guz A. The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans. J Physiol 1994; 476: 141-51.
16. Harms C, Zeng Y, Smith C, Vidruk E, Dempsey J. Negative pressure-induced deformation of the upper airway causes central apnea in awake and sleeping dogs. J Appl Physiol 1996; 80:1528-39.
17. Badr M. Pathophysiology of upper airway obstruction during sleep. Clin Chest Med 1998; 19: 21-32.
18. Davies RJ, Ali NJ, Stradling JR. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992; 47(2): 101-5.
19. Eikermann M, Jordan A, Chamberlin N et al. The influence of aging on pharyngeal collapsibility during sleep. Chest 2007; 131: 1702-9.
20. Rowley J, Zhou X, Diamond M, Badr M. The determinants of the apnea threshold during NREM sleep in normal subjects. Sleep 2006; 29: 95-103.
21. Shepertycky M, Banno K, Kryger M. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 2005; 28: 309-14.
22. Nieto FJ, Young TB, Lind E et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community- based study. JAMA 2000; 283: 1829-36.
23. Peppard P, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
24. Weaver T, Kribbs N, Pack A et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997; 20: 278-383.
25. Veasey S, Guilleminault C, Strohl K et al. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006; 29: 1036-44.
26. SIGN. Management of obstructive sleep apnoea/hypopnoea syndrome in adults (Guideline No. 73). www.sign.ac.uk. 2003.
27. Veasey S. Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential. Am J Respir Med 2003; 2: 21-9.
28. Hanzel D, Proia N, Hudgel D. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991; 100: 416-21.
29. Berry R, Yamaura E, Gill K, Reist C. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep 1999; 22: 1087-92.
30. Kraiczi H, Hedner J, Dahlof P, Ejnell H, Carlson J. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999; 22: 61-7.
31. Kass J, Akers S, Bartter T, Pratter M. Rapid-eye-movementspecific sleep-disordered breathing: a possible cause of excessive daytime sleepiness. Am J Respir Crit Care Med 1996; 154:167-9.
32. Smith P, Haponik E, Allen R, Bleecker E. The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis 1983; 127: 8-13.
33. Brownell L, West P, Sweatman P, Acres J, Kryger M. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med 1982; 307: 1037-42.
34. Issa F. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 1992; 145: 435-9.
35. Zevin S, Swed E, Cahan C. Clinical effects of locally delivered nicotine in obstructive sleep apnea syndrome. Am J Ther 2003; 10: 170-5.
36. Braver H, Block A. Effect of nasal spray, positional therapy, and the combination thereof in the asymptomatic snorer. Sleep 1994; 17: 516-21.
37. Kiely J, Nolan P, McNicholas W. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax 2004; 59: 50-5.
38. Sullivan C, Issa F, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 8225: 862-5.
39. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997; 52: 114-19.
40. Engleman HM, Kingshott RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep 2000; 23(Suppl 4): S102-8.
41. Lim J, Lasserson T, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev 2006; 25: CD004435.
42. Barnes M, McEvoy R, Banks S et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170: 656-64.
43. Schwartz A, Gold A, Schubert N et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991; 144: 494-8.
44. Kansanen M, Vanninen E, Tuunainen A et al. The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998; 18: 377-85.
45. Kajaste S, Brander P, Telakivi T, Partinen M, Mustajoki P. A cognitive- behavioural weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004; 5: 125-31.
46. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.
47. Livingston E. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg 2004; 188: 105-10.
48. Chauncey J, Aldrich M. Preliminary findings in the treatment of obstructive sleep apnea with transtracheal oxygen. Sleep 1990; 13: 167-74.
49. Phillips B, Schmitt F, Berry D et al. Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest 1990; 98: 325-30.
50. Farney R, Walker J, Elmer J, Viscomi V, Ord R. Transtracheal oxygen, nasal CPAP and nasal oxygen in five patients with obstructive sleep apnea. Chest 1992; 101: 1228-35.
51. Spengler C, Gozal D, Shea SA. Chemoreceptive mechanisms elucidated by studies of congenital central hypoventilation syndrome. Respir Physiol 2001; 129: 247-55.
52. Morrell MJ, Haywood P, Moosavi SH, Stevens J, Guz A. Unilateral focal lesions in the rostrolateral medulla influence chemosensitivity and breathing measured during wakefulness, sleep and exercise. J Neurol Neurosurg Psychiatry 1999; 67:637-45.
53. Xie A, Wong B, Phillipson EA, Slutsky AS, Bradley TD. Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med 1994; 150: 489-95.
54. Nickol A, Leverment J, Richards P et al. Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study. J Sleep Res 2006; 15: 445-54.
55. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med Sep 1999; 341: 949-54.
56. Javaheri S, Parker TJ, Liming JD et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-9.
57. Bradley TD, Phillipson EA. Central sleep apnea. Clin Chest Med 1992; 13: 493-505.
58. Xie A, Skatrud J, Puleo D, Rahko P, Dempsey J. Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med 2002; 165: 1245-50.
59. Mansfield D, Kaye DM, Brunner La Rocca H et al. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 2003; 107: 1396-400.
60. Solin P, Bergin P, Richardson M et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999; 99: 1574-9.
61. Lorenzi-Filho G, Azevedo ER, Parker JD, Bradley TD. Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J 2002; 19:37-40.
62. Cohn J, Levine T, Olivari M et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 19-23.
63. Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151: 92-7.
64. Bradley TD, Floras JS. Pathophysiologic and therapeutic implications of sleep apnea in congestive heart failure. J Card Fail 1996; 2: 223-40.
65. Hanly P, Zuberi-Khokhar N. Daytime sleepiness in patients with congestive heart failure and Cheyne-Stokes respiration. Chest 1995; 107: 952-8.
66. Staniforth A, Kinnear W, Cowley A. Cognitive impairment in heart failure with Cheyne-Stokes respiration. Heart 2001; 85:18-22.
67. Hastings PC, Vazir A, O’Driscoll DM, Morrell MJ, Simonds AK. Symptom burden of sleep-disordered breathing in mild-to-moderate congestive heart failure patients. Eur Respir J 2006; 27: 748-55.
68. Sin DD, Fitzgerald F, Parker JD et al. Risk factors for central and obstructive sleep apnea in 450 men and women with con - gestive heart failure. Am J Respir Crit Care Med 1999; 160:1101-6.
69. Javaheri S, Parker TJ, Wexler L et al. Occult sleep-disordered breathing in stable congestive cardiac failure. Ann Intern Med 1995; 122: 487-92.
70. Walsh J, Andrews R, Starling R et al. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 1995; 73: 237-41.
71. Packer M, Coats A, Fowler M et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344:1651-8.
72. Pepin J, Chouri-Pontarollo N, Tamisier R, Levy P. Cheyne-Stokes respiration with central sleep apnoea in chronic heart failure: proposals for a diagnostic and therapeutic strategy. Sleep Med Rev 2006; 10: 33-47.
73. Javaheri S, Parker T, Wexler L et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996; 335: 562-7.
74. Bittar G, Friedman H. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991; 99: 1415-20.
75. Suissa S, Hemmelgarn B, Blais L, Ernst P. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 1996; 154:1598-602.
76. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006; 173: 234-7.
77. White DP, Zwillich CW, Pickett CK et al. Central sleep apnea. Improvement with acetazolamide therapy. Arch Intern Med 1982; 142: 1816-19.
78. DeBacker W, Verbraecken J, Willemen M et al. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995; 151: 87-91.
79. Sutton J, Houston C, Mansell A et al. Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med 1979; 301: 1329-31.
80. Guilleminault C, Clerk A, Labanowski M, Simmons J, Stoohs R. Cardiac failure and benzodiazepines. Sleep 1993; 16: 524-8.
81. Arzt M, Bradley T. Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006; 173: 1300-8.
82. Kaneko Y, Floras JS, Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-41.
83. Mansfield DR, Gollogly NC, Kaye DM et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169:361-6.
84. Naughton MT, Benard DC, Liu PP et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995; 152: 473-9.
85. Naughton MT, Benard DC, Rutherford R, Bradley TD. Effect of continuous positive airway pressure on central sleep apnea and nocturnal PCO2 in heart failure. Am J Respir Crit Care Med 1994; 150: 1598-604.
86. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61-6.
87. Javaheri S. Treatment of central sleep apnea in heart failure. Sleep 2000; 23(Suppl 4): S224-7.
88. Bradley TD, Logan AG, Kimoff RJ et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-33.
89. Teschler H, Dohring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001; 164(4): 614-19.
90. Kohnlein T, Welte T, Tan L, Elliott M. Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J 2002; 20: 934-41.
91. Francis D, Willson K, Davies L, Coats A, Piepoli M. Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation 2000; 102: 2214-21.
92. Andreas S, Clemens C, Sandholzer H, Figulla H, Kreuzer H. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996; 27: 1486-90.
93. Krachman S, D’Alonzo G, Berger T, Eisen H. Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 1999; 116: 1550-7.
94. Staniforth A, Kinnear W, Starling R, Cowley A. Nocturnal desaturation in patients with stable heart failure. Heart 1998; 79: 394-9.
95. Haque W, Boehmer J, Clemson B et al. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 1996; 27: 353-7.
96. Xie A, Rankin F, Rutherford R, Bradley TD. Effects of inhaled CO2 and added dead space on idiopathic central sleep apnea. J Appl Physiol 1997; 82: 918-26.
97. Szollosi I, Jones M, Morrell MJ, Helfet K, Simonds A. Effect of CO2 inhalation on central sleep apnea and arousals from sleep. Respiration 2004; 71: 493-8.
98. Khayat R, Xie A, Patel A, Kaminski A, Skatrud J. Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest 2003; 123: 1551-60.